# Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes

> **NCT06746610** · NA · RECRUITING · sponsor: **Tianjin Medical University General Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Monogenic Diabetes

## Interventions

- **DIAGNOSTIC_TEST:** Genetic Screening for Monogenic Diabetes

## Key facts

- **NCT ID:** NCT06746610
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06746610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06746610, "Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06746610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*